血友病の疫学的予測（～2024）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.3 Global Trends 11
3.4 Forecast Methodology 13
3.4.1 Sources Used 13
3.4.2 Sources Not Used 14
3.4.3 Forecast Assumptions and Methods 15
3.5 Epidemiological Forecast for Hemophilia A (2014-2024) 19
3.5.1 Diagnosed Prevalent Cases of Hemophilia A 19
3.5.2 Diagnosed Prevalent Cases of Hemophilia A by Age 20
3.5.3 Diagnosed Prevalent Cases of Hemophilia A by Sex 22
3.5.4 Age-Standardized Diagnosed Prevalence of Hemophilia A 24
3.6 Epidemiological Forecast for Hemophilia B (2014-2024) 26
3.6.1 Diagnosed Prevalent Cases of Hemophilia B 26
3.6.2 Diagnosed Prevalent Cases of Hemophilia B by Age 27
3.6.3 Diagnosed Prevalent Cases of Hemophilia B by Sex 29
3.6.4 Age-Standardized Diagnosed Prevalence of Hemophilia B 31
3.7 Epidemiological Forecast for Hemophilia A and Hemophilia B (2014-2024) 32
3.7.1 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B 32
3.7.2 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Sex 34
3.8 Discussion 36
3.8.1 Conclusions on Epidemiological Trends 36
3.8.2 Limitations of the Analysis 37
3.8.3 Strengths of the Analysis 38
4 Appendix 39
4.1 Bibliography 39
4.2 About the Authors 41
4.2.1 Epidemiologists 41
4.2.2 Reviewers 42
4.2.3 Global Director of Epidemiology and Health Policy 42
4.2.4 Global Head of Healthcare 43
4.3 About GlobalData 44
4.4 About EpiCast 44
4.5 Disclaimer 45